References
Selvi I, Demirci U, Bozdogan N, Basar H (2020) The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results. Int UrolNephrol 52:21–34. https://doi.org/10.1007/s11255-019-02285-0
Guo C, Zhao H, Wang Y, Bai S, Yang Z, Wei F et al (2019) Prognostic value of the neoimmunoscore in renal cell carcinoma. Front Oncol 9:439. https://doi.org/10.3389/fonc.2019.00439
Yao JX, Chen X, Xi W, Zhu YJ, Wang H, Hu XY et al (2018) Immunoscore system for predicting clinical outcome of metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. J Cancer 9(22):4099–4107. https://doi.org/10.7150/jca.27408
Anitei MG, Zeitoun G, Mlecnik B, Marliot F, Haicheur N, Todosi AM et al (2014) Prognostic and predictive values of the immunoscore in patients with rectal cancer. Clin Cancer Res 20(7):1891–1899. https://doi.org/10.1158/1078-0432.CCR-13-2830
Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen EE, Hald SM et al (2016) Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Ann Oncol 27(2):225–232. https://doi.org/10.1093/annonc/mdv560
Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T et al (2011) Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 29:610–618. https://doi.org/10.1200/JCO.2010.30.5425
Ljungberg B, Albiges L, Bensalah K, Bex A, Giles RH, Hora M, et al (2020) European Association of Urology guidelines on renal cell carcinoma: the 2020 Update. EAU Guidelines Office, Arnhem, The Netherlands. Available from: https://uroweb.org/guideline/renal-cell-carcinoma/. Accessed 1 Dec 2020
Delahunt B, Eble JN, Egevad L, Samaratunga H (2019) Grading of renal cell carcinoma. Histopathology 74:4–17. https://doi.org/10.1111/his.13735
Funding
This work is financially supported by Health Science University Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital through the scientific research fund with the decision of dated 03.11.2017 and numbered 1.
Author information
Authors and Affiliations
Contributions
IS: conception and design, Acquisition of data, statistical analysis, analysis and ınterpretation of data, drafting of the manuscript. UD: conception and design, critical revision of the manuscript for important intellectual content. NB: analysis and ınterpretation of data, pathological evaluation, critical revision of the manuscript for important intellectual content. HB: critical revision of the manuscript for important intellectual content.
Corresponding author
Ethics declarations
Conflict of ınterest
The authors declare that they have no conflict of interest.
Ethical approval for research involving human participants.
The study was approved by the local ethics committee (the protocol number: 2018–02/18; the date of approval: February 7, 2018) at Health Science University Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. All procedures performed in our study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
A formal written informed consent was obtained from all individual participants included in the study. The data of patients who did not consent was not used.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Selvi, I., Demirci, U., Bozdogan, N. et al. Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?. Int Urol Nephrol 53, 1135–1138 (2021). https://doi.org/10.1007/s11255-020-02766-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02766-7